A megalin polymorphism associated with promoter activity and Alzheimers disease riskDisclosure statement: There are no actual or potential conflicts of interest with other people or organizations. Human studies were approved by the Ethics Committee of the Hospital ‘12 de Octubre’, Hospital Clínico de San Carlos, and Hospital Universitario La Paz in Madrid Spain, Hospital Santa Creu i Sant Pau in Barcelona Spain, Hospital Universitario Marqués de Valdecilla in Santander Spain and Institute Pere Mata in Reus Spain, and informed consent was obtained from all patients prior to their participation.Teo Vargas and Maria Jesus Bullido contributed equally to this work.How to Cite this Article: Vargas T, Bullido MJ, MartinezGarcia A, Antequera D, Clarimon J, RosichEstrago M, MartinRequero A, Mateo I, RodriguezRodriguez E, VilellaCuadrada E, Frank A, Lleo A, MolinaPorcel L, Blesa R, Combarros O, GomezIsla T, BermejoPareja F, Valdivieso F, Carro E. 2010. A Megalin Polymorphism Associated With Prom

Autor: Vargas, Teo, Bullido, Maria Jesus, MartinezGarcia, Ana, Antequera, Desiree, Clarimon, Jordi, RosichEstrago, Marcel, MartinRequero, Angeles, Mateo, Ignacio, RodriguezRodriguez, Eloy, VilellaCuadrada, Elisabet, Frank, Ana, Lleo, Alberto, MolinaPorcel, Laura, Blesa, Rafael, Combarros, Onofre, GomezIsla, Teresa, BermejoPareja, Felix, Valdivieso, Fernando, Carro, Eva

Publikováno v: American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics; June 2010, Vol. 153 Issue: 4 p895-902, 8p